These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38225440)

  • 21. Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.
    Moriyama T; Nakayama K; Ochi A; Amemiya N; Tsuruta Y; Kojima C; Itabashi M; Takei T; Uchida K; Nitta K
    Clin Exp Nephrol; 2012 Apr; 16(2):231-7. PubMed ID: 22038185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary exosomal mRNAs as biomarkers for predicting the therapeutic effect of renin-angiotensin system inhibitors in IgA nephropathy patients.
    Zhao B; Wang M; Cong Y; Song A; Lu J; Xie K; Dai H; Gu L
    Clin Chim Acta; 2024 Jul; 561():119750. PubMed ID: 38885756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
    Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severity of arterial and/or arteriolar sclerosis in IgA nephropathy and the effects of renin-angiotensin system inhibitors on its prognosis.
    Sugiura N; Moriyama T; Miyabe Y; Karasawa K; Nitta K
    J Pathol Clin Res; 2021 Nov; 7(6):616-623. PubMed ID: 34185389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy.
    Hogg RJ; Bay RC; Jennette JC; Sibley R; Kumar S; Fervenza FC; Appel G; Cattran D; Fischer D; Hurley RM; Cerda J; Carter B; Jung B; Hernandez G; Gipson D; Wyatt RJ
    Am J Kidney Dis; 2015 Nov; 66(5):783-91. PubMed ID: 26209543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hematuria on the outcome of IgA nephropathy with mild proteinuria.
    Tanaka K; Moriyama T; Iwasaki C; Takei T; Nitta K
    Clin Exp Nephrol; 2015 Oct; 19(5):815-21. PubMed ID: 25475403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy an ACE inhibitor and an angiotensin receptor blocker for IgA nephropathy: a meta-analysis.
    Cheng J; Zhang X; Tian J; Li Q; Chen J
    Int J Clin Pract; 2012 Oct; 66(10):917-23. PubMed ID: 22994326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
    Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual effect of renin-angiotensin system inhibition and corticosteroid therapy in IgA glomerulonephritis: results of a pilot study.
    Kim MJ; Hopfer H; Koller MT; Giannini O; Mihatsch MJ; Mayr M
    Clin Nephrol; 2010 Feb; 73(2):122-30. PubMed ID: 20129019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy.
    Lou T; Wang C; Chen Z; Shi C; Tang H; Liu X; Yin P; Yu X
    Nephrology (Carlton); 2006 Apr; 11(2):113-6. PubMed ID: 16669971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study.
    Yang YZ; Chen P; Liu LJ; Cai QQ; Shi SF; Chen YQ; Lv JC; Zhang H
    BMC Nephrol; 2019 Aug; 20(1):297. PubMed ID: 31382914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
    Li S; Li JP
    Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tonsillectomy plus steroid pulse therapy is the most effective treatment in adult patients with C-Grade I IgA nephropathy, and the weight of the extracted palatine tonsils and Yamamoto scale have no significant correlation with the effects of this treatment.
    Kondo N; Moriyama T; Tachikawa M; Tomita E; Hattori A; Yamamura Y; Nonaka M
    Auris Nasus Larynx; 2019 Oct; 46(5):764-771. PubMed ID: 30665673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children.
    Vaz de Castro PAS; Bitencourt L; Pereira BWS; Lima AQR; Hermida HS; Moreira Neto CR; Mestriner MD; Simões E Silva AC
    Pediatr Nephrol; 2022 Mar; 37(3):499-508. PubMed ID: 34686915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.
    Rauen T; Eitner F; Fitzner C; Sommerer C; Zeier M; Otte B; Panzer U; Peters H; Benck U; Mertens PR; Kuhlmann U; Witzke O; Gross O; Vielhauer V; Mann JF; Hilgers RD; Floege J;
    N Engl J Med; 2015 Dec; 373(23):2225-36. PubMed ID: 26630142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
    Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
    Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of hydroxychloroquine in patients with IgA nephropathy with insufficient responses to immunosuppressive therapy: a retrospective case-control study.
    Tang C; Lv JC; Shi SF; Chen YQ; Liu LJ; Zhang H
    BMC Nephrol; 2020 Nov; 21(1):469. PubMed ID: 33172397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C; Torres DD; Rossini M; Pesce F; Schena FP
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment and outcome of IgA nephropathy in children from one single center experience.
    Mao Y; Zhou W; Zhou Z; Zhang C; Shen J; Yin L
    BMC Pediatr; 2023 Jul; 23(1):377. PubMed ID: 37495962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.